0002019976-24-000004.txt : 20240503
0002019976-24-000004.hdr.sgml : 20240503
20240503164028
ACCESSION NUMBER: 0002019976-24-000004
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240424
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novack Jeffrey Adam
CENTRAL INDEX KEY: 0002019976
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 24913904
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
3
1
wk-form3_1714768810.xml
FORM 3
X0206
3
2024-04-24
0
0001217234
CareDx, Inc.
CDNA
0002019976
Novack Jeffrey Adam
C/O CAREDX, INC.
8000 MARINA BOULEVARD
BRISBANE
CA
94005
0
1
0
0
Secretary and General Counsel
Common Stock
126974
D
Employee Stock Option (right to buy)
18.24
2032-08-06
Common Stock
2385
D
Employee Stock Option (right to buy)
37.25
2032-04-06
Common Stock
2150
D
Comprised of 7,341 shares of common stock and 119,633 shares of common stock represented by restricted stock units ("RSUs"). The RSUs consist of (1) 5,000 shares granted on November 6, 2021; (2) 7,150 shares granted on April 6, 2022; (3) 1,600 shares granted on August 6, 2022; (4) 11,655 shares granted on November 7, 2022; (5) 7,500 shares granted on April 6, 2023; (6) 10,000 shares granted on June 6, 2023; (7) 10,000 shares granted on July 6, 2023; and (8) 66,728 shares granted on February 1, 2024. Each of the foregoing RSU grants is subject to its own vesting schedule.
The option was originally granted on August 6, 2022. 1/4th of the shares subject to the option vested on August 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.
The option was originally granted on April 6, 2022. 1/4th of the shares subject to the option vested on April 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.
/s/ Jeffrey Adam Novack
2024-05-03